To help clinicians understand the foundation of pharmacology and new therapies as they pertain to inflammatory bowel disease (IBD), AGA has released a free, on-demand course through AGA University.
Designed by clinical nurse practitioners and presented in a case-based format, Advanced Practice Provider Pharmacology: IBD covers the three most prevalent pharmacological treatments for IBD: 5-aminosalicylic acid (5-ASA) drugs, biologics and immunomodulators.
Why participate?
- Complimentary access. This program is available to all AGA members and nonmembers through AGA University. Easily accessible from home or the office, participants can plan a lunch-and-learn with peers or learn at their own pace.
- Learn from esteemed colleagues. This two-hour course provides a comprehensive overview for GI professionals of all levels. Expert faculty include Kimberly Kearns, MS, APRN, ANP-BC (Chair), Erin Darguzas, MSN, APN, and Shawna Sullivan, MSN, APRN, ACNP-BC.
- Earn continuing education credit. After competition of this course, participants will be eligible to receive 2 AMA PRA Category 1 Credits™ or 2 pharmacology credit hours through AANP.
Gain the knowledge you need to remain a leader in the field — participate in Advanced Practice Provider Pharmacology: IBD today!
This program was supported by independent educational grants from Gilead Sciences, Inc. and Takeda Pharmaceuticals U.S.A., Inc.
